References
Buck RE, Price KE. Cefadroxil, a new spectrum cephalosporin. Antimicrobial Agents and Chemotherapy 11: 234, 1977
Isaacson DM, Foleno BD, Hilliard JJ, Tolman EL, McQuire JL, et al. In vitro activity of ofloxacin against respiratory tract pathogens including both Gram-positive and Gram-negative organisms. 14th International Congress of Chemotherapy, Kyoto, Japan, June 23–28, 1985
Lucht F, Tigaud S, Noel F, Peyramond D. Experience with ofloxacin in the treatment of enterai infections. International Symposium on New Quinolones. Abstracts, Geneva, Switzerland, July 17–19, p. 211, 1986
Sabbour MS, Osman LM. The changing pattern of urinary tract pathogens in Egypt. Farmacia & Terapia 2: 35–41, 1985
Stanton RA. Urinary tract infection. Problems in diagnosis and management. Medical Clinics of North America 58: 545–549, 1973
Washington JA, Sutter VL (Eds). Dilution susceptibility test: agar and macrobroth dilution procedures. In Manual of clinical microbiology, 3rd edition, pp. 453–458, 1980
Wongwanich S, Ramsiri S, Tanak H, Phan-Vrai R. Comparative in vitro activity of ofloxacin (DL-8280) and other antimicrobial agents against enteric and miscellaneous bacteria. 14th International Congress of Chemotherapy, Kyoto, Japan, June 23–28, 1985
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sabbour, M.S., Osman, L.M., Abd-El-Hamid, T. et al. Present Day Susceptibility of Urinary Pathogens to Antimicrobials. Drugs 34 (Suppl 1), 176–177 (1987). https://doi.org/10.2165/00003495-198700341-00037
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-198700341-00037